BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kemmer N, Kaiser T, Zacharias V, Neff G. Alpha-1-Antitrypsin Deficiency: Outcomes After Liver Transplantation. Transplantation Proceedings 2008;40:1492-4. [DOI: 10.1016/j.transproceed.2008.02.075] [Cited by in Crossref: 57] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Udompap P, Kim D, Kim WR. Current and Future Burden of Chronic Nonmalignant Liver Disease. Clin Gastroenterol Hepatol. 2015;13:2031-2041. [PMID: 26291665 DOI: 10.1016/j.cgh.2015.08.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 11.5] [Reference Citation Analysis]
2 Fagiuoli S, Daina E, D'Antiga L, Colledan M, Remuzzi G. Monogenic diseases that can be cured by liver transplantation. J Hepatol. 2013;59:595-612. [PMID: 23578885 DOI: 10.1016/j.jhep.2013.04.004] [Cited by in Crossref: 81] [Cited by in F6Publishing: 59] [Article Influence: 10.1] [Reference Citation Analysis]
3 Townsend SA, Edgar RG, Ellis PR, Kantas D, Newsome PN, Turner AM. Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease. Aliment Pharmacol Ther. 2018;47:877-885. [PMID: 29446109 DOI: 10.1111/apt.14537] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 12.3] [Reference Citation Analysis]
4 Finotti M, Auricchio P, Vitale A, Gringeri E, Cillo U. Liver transplantation for rare liver diseases and rare indications for liver transplant. Transl Gastroenterol Hepatol 2021;6:27. [PMID: 33824931 DOI: 10.21037/tgh-19-282] [Reference Citation Analysis]
5 Pietrangelo A. Inherited metabolic disease of the liver. Curr Opin Gastroenterol 2009;25:209-14. [PMID: 19342951 DOI: 10.1097/MOG.0b013e328329e13d] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
6 Mitchell EL, Khan Z. Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions. Curr Pathobiol Rep 2017;5:243-52. [PMID: 29399420 DOI: 10.1007/s40139-017-0147-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
7 Nyon MP, Gooptu B. Therapeutic targeting of misfolding and conformational change in α 1 -antitrypsin deficiency. Future Medicinal Chemistry 2014;6:1047-65. [DOI: 10.4155/fmc.14.58] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
8 Nelson DR, Teckman J, Di Bisceglie AM, Brenner DA. Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency. Clin Gastroenterol Hepatol 2012;10:575-80. [PMID: 22200689 DOI: 10.1016/j.cgh.2011.12.028] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
9 Darwish AA, Mckiernan P, Chardot C. Paediatric liver transplantation for metabolic disorders. Part 2: Metabolic disorders with liver lesions. Clinics and Research in Hepatology and Gastroenterology 2011;35:271-80. [DOI: 10.1016/j.clinre.2011.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
10 Dickens JA, Lomas DA. Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis. Drug Des Devel Ther 2011;5:391-405. [PMID: 21966212 DOI: 10.2147/DDDT.S14018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
11 Lachaux A, Dumortier J. [Hepatic involvement in hereditary alpha-1-antitrypsin deficiency]. Rev Mal Respir 2014;31:357-64. [PMID: 24750955 DOI: 10.1016/j.rmr.2013.10.651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol 2013;59:367-74. [PMID: 23557870 DOI: 10.1016/j.jhep.2013.03.026] [Cited by in Crossref: 75] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
13 Clark VC. Liver Transplantation in Alpha-1 Antitrypsin Deficiency. Clin Liver Dis 2017;21:355-65. [PMID: 28364818 DOI: 10.1016/j.cld.2016.12.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
14 Hyzny EJ, Chan EG, Morrell M, Harano T, Sanchez PG. A review of liver dysfunction in the lung transplant patient. Clin Transplant 2021;:e14344. [PMID: 33960530 DOI: 10.1111/ctr.14344] [Reference Citation Analysis]
15 Köhnlein T, Rifai K. [Alpha1-antitrypsin deficiency]. Internist (Berl) 2010;51 Suppl 1:269-76. [PMID: 20135085 DOI: 10.1007/s00108-009-2505-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Raevens S, Boret M, De Pauw M, Fallon MB, Van Vlierberghe H. Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome. Hepatology 2021. [PMID: 33636019 DOI: 10.1002/hep.31770] [Reference Citation Analysis]
17 Arias P, Kerner J, Christofferson M, Berquist W, Park KT. Misdiagnosis of α-1 antitrypsin phenotype in an infant with CMV infection and liver failure. Dig Dis Sci 2014;59:1710-3. [PMID: 24633574 DOI: 10.1007/s10620-014-3094-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
18 Tacke F, Trautwein C. Controlling autophagy: a new concept for clearing liver disease. Hepatology. 2011;53:356-358. [PMID: 21254183 DOI: 10.1002/hep.24090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
19 Hadzic N. Therapeutic Options in Alpha-1 Antitrypsin Deficiency: Liver Transplantation. In: Borel F, Mueller C, editors. Alpha-1 Antitrypsin Deficiency. New York: Springer; 2017. pp. 263-5. [DOI: 10.1007/978-1-4939-7163-3_26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Cardoso FS, Karvellas CJ. Respiratory Complications Before and After Liver Transplant. J Intensive Care Med 2019;34:355-63. [PMID: 29886790 DOI: 10.1177/0885066618781526] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Carey EJ, Iyer VN, Nelson DR, Nguyen JH, Krowka MJ. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency-related cirrhosis: LT for AAT Deficiency-Related Cirrhosis. Liver Transpl 2013;19:1370-6. [DOI: 10.1002/lt.23744] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
22 Sabbagh DK, Barmayehvar B, Nguyen T, Edgar RG, Turner AM. Managing panniculitis in alpha-1 antitrypsin deficiency: Systematic review of evidence behind treatment. WJD 2018;7:1-8. [DOI: 10.5314/wjd.v7.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
23 Guillaud O, Jacquemin E, Couchonnal E, Vanlemmens C, Francoz C, Chouik Y, Conti F, Duvoux C, Hilleret MN, Kamar N, Houssel-Debry P, Neau-Cransac M, Pageaux GP, Gonzales E, Ackermann O, Gugenheim J, Lachaux A, Ruiz M, Radenne S, Debray D, Lacaille F, McLin V, Duclos-Vallée JC, Samuel D, Coilly A, Dumortier J. Long term results of liver transplantation for alpha-1 antitrypsin deficiency. Dig Liver Dis 2021;53:606-11. [PMID: 33139195 DOI: 10.1016/j.dld.2020.10.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144-1165. [PMID: 24716201 DOI: 10.1002/hep.26972] [Cited by in Crossref: 429] [Cited by in F6Publishing: 288] [Article Influence: 61.3] [Reference Citation Analysis]
25 Fox AN, Brown RS. Is the Patient a Candidate for Liver Transplantation? Clinics in Liver Disease 2012;16:435-48. [DOI: 10.1016/j.cld.2012.03.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]